Biotech Values

[DewDiligence]

FSTX -40% on US government blockage of buyout by China’s Sino Biopharm—at least for now:

https://www.sec.gov/ix?doc=/Archives/edgar/data/0001566373/000119312522314185/d421497d8k.htm

Effective at December 29, 2022 at 12:05 a.m. Eastern Time, the Committee on Foreign Investment in the United States (“CFIUS”) issued an order (the “Interim Order”) preventing the consummation of the transactions pursuant to the Merger Agreement, citing unresolved national security risks.

…The Interim Order is for an indeterminate duration, lasting until: (1) CFIUS concludes action under Section 721 with respect to the transaction; (2) the President of the United States (“President”) takes action or declines to take action under Section 721 with respect to the transaction; or (3) CFIUS or the President revokes or terminates this Interim Order.

Emphasis added.